M. Gasior et al., FELBAMATE DEMONSTRATES LOW PROPENSITY FOR INTERACTION WITH METHYLXANTHINES AND CA2+ CHANNEL MODULATORS AGAINST EXPERIMENTAL SEIZURES IN MICE, European journal of pharmacology, 352(2-3), 1998, pp. 207-214
The aim of this study was to determine the interaction potential of th
e new antiepileptic drug felbamate (2-phenyl-1,3-propanediol dicarbama
te) with three Ca2+ channel blockers (nicardipine, nifedipine, and flu
narizine), one Ca2+ channel activator (Bay K 8644; -5-nitro-4-[2-(trif
luoromethyl)-phenyl]-3-pyridine carboxylic acid), and two methylxanthi
nes (caffeine and aminophylline (theophylline(2).ethylenediamine)) whi
ch are all known to markedly change protective effects of conventional
antiepileptic drugs. To do so, the maximal electroshock seizure test
in mice (an experimental model predicting drug efficacy in the treatme
nt of human generalized tonic-clonic seizures) was employed to (1) qua
ntify changes in the protective efficacy and potency of felbamate prod
uced by adjunct drugs and (2) assess the ability of aminophylline and
caffeine to affect protective efficacy afforded by a submaximal protec
tive dose of felbamate against maximal electroshock-induced seizures.
Doses of adjunct drugs were selected based on their effects on the thr
eshold for electroconvulsions and on appropriate Literature. Nicardipi
ne (10-30 mg/kg), nifedipine (5-20 mg/kg), flunarizine (2.5-10 mg/kg),
Bay K 8644 (2.5-5 mg/kg), and aminophylline (50-75 mg/kg) did not cha
nge the protective efficacy and potency of felbamate against maximal e
lectroshock-induced tonic convulsions. Aminophylline in the dose of 10
0 mg/kg, however, diminished the protective potency of felbamate as ev
idenced by a statistically significant increase in the protective ED50
value of felbamate (a dose, in mg/kg, predicted to protect 50% of mic
e against convulsive stimulus) from 79.6 to 118 mg/kg; P < 0.05). Amin
ophylline and caffeine only at high doses (100 and 161.7 mg/kg, respec
tively) significantly diminished the protective efficacy of felbamate
(110 mg/kg) from 96% to 27% and 40% (P < 0.05), respectively. In concl
usion, felbamate shows low interaction potential with Ca2+ channel mod
ulators and methylxanthines. Such low interaction potential clearly di
fferentiates felbamate from conventional antiepileptic drugs where pro
tective effects are readily altered by the compounds tested in the pre
sent study. (C) 1998 Elsevier Science B.V. All rights reserved.